Lifestyle changes may boost the success of microbial transplants in people with diabetes

Repeated fecal microbiota transplants can improve the gut colonization of beneficial microbes in people with obesity and type 2 diabetes.

The microbiota may contribute to chronic liver disease by activating immune cells

To elucidate the role of the microbiota in PSC, researchers studied a type of immune cells called mucosal-associated invariant T (MAIT) cells, which are abundant in the liver.

Akkermansia municiphila on the market before the end of 2022

Patrice Cani (Université catholique de Louvain) discusses the future of Akkermansia municiphila.

Gut microbes may help frogs handle heat

Researchers have found that gut microbes can help frogs to cope with hot temperatures. The findings could pave the way to for new conservation approaches for animals threatened by climate…

Gut microbes may contribute to damage the aging brain’s immune cells

The impact of age-induced microbiota alterations facilitates the accumulation of CML metabolite in the microglia of mice and humans.

Microbial metabolite may boost antitumor immunity in aggressive breast cancer

Researchers have found that a specific microbial metabolite may boost the efficacy of anticancer therapy in people with TNBC. The findings could inform the development of improved treatments for TNBC.

Probiota 2022: progress and challenges on microbiome space

George Paraskevakos (International Probiotics Association) discusses the challenges on microbiome space.

MaaT Pharma’s ARES clinical study: Phase 3 in the evaluation of MaaT013 in patients with aGvHDA

MaaT Pharma has established a comprehensive approach to restoring the patient-microbiome symbiosis in oncology.

Lung microbiota may influence outcome of bone marrow transplant

New research investigates the role of lung microbiota in pediatric patients with lung infection or injury after bone marrow transplantation.

Gut microbes change in people with heart conditions long before disease symptoms

Researchers uncover the gut microbiota changes that happen in the very early stages of heart disease. The microbial and metabolic profiles identified could be used as markers of the transition…

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top